![Kiran Reddy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kiran Reddy
Private-Equity-Analyst bei
BLACKSTONE INC.
Profil
Kiran Reddy is the founder of Praxis Precision Medicines, Inc. (founded in 2015) where he held the title of Director from 2020 to 2021.
He is currently working as a Managing Director & Venture partner at Blackstone, Inc. and as a Senior Managing Director at Blackstone Life Sciences Advisors LLC (since 2018 and 2022 respectively).
Previously, he worked as a Senior Director at Biogen, Inc. from 2014 to 2016, as a Consultant at The Lewin Group, Inc., as a Venture Partner at Clarus Ventures LLC from 2015 to 2018, as a Senior Associate at Third Rock Ventures LLC from 2008 to 2010, and as the Head of Business Development & Operations at SAGE Therapeutics, Inc. from 2012 to 2013.
Dr. Reddy completed his undergraduate degree at Georgetown University in 1999 and obtained an MBA in 2004.
He also holds a doctorate degree, which was conferred in 2003.
Aktive Positionen von Kiran Reddy
| Unternehmen | Position | Beginn |
|---|---|---|
| BLACKSTONE INC. | Private-Equity-Analyst | 05.01.2020 |
Blackstone Life Sciences Advisors LLC
 Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields on pharmaceutical, biotechnology and medical technology sectors. It provides financing for growth stage transactions. | Private Equity Investor | 01.12.2018 |
Ehemalige bekannte Positionen von Kiran Reddy
| Unternehmen | Position | Ende |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Vorstandsvorsitzender | 01.04.2020 |
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of biopharmaceutical and medical technology. It participates in early stage capital transactions. Clarus Ventures acquired by Blackstone Inc on November 30, 2018. Clarus ventures will become Blackstone Life Sciences. | Private Equity Investor | 11.01.2018 |
| BIOGEN INC. | Corporate Officer/Principal | 06.01.2016 |
The Lewin Group, Inc.
 The Lewin Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides healthcare consulting services | Corporate Officer/Principal | - |
| SAGE THERAPEUTICS, INC. | Geschäftsführer | 14.03.2013 |
Ausbildung von Kiran Reddy
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
46
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
The Lewin Group, Inc.
The Lewin Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides healthcare consulting services | Commercial Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clarus Ventures LLC
Clarus Ventures LLC Investment ManagersFinance Clarus Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of biopharmaceutical and medical technology. It participates in early stage capital transactions. Clarus Ventures acquired by Blackstone Inc on November 30, 2018. Clarus ventures will become Blackstone Life Sciences. | Finance |
Blackstone, Inc.
 Blackstone, Inc. Investment ManagersFinance Provides alternative asset management services | Finance |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finance |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Praxis Precision Medicines, Inc.
 Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
Blackstone Life Sciences Advisors LLC
Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields on pharmaceutical, biotechnology and medical technology sectors. It provides financing for growth stage transactions. | Finance |
